Evaluation of phenotypic and genotypic approaches as predictors of Salmonella strains of clinical and non-clinical origin by Dorr, Paul M. et al.
O
R
A
L
P
R
E
S
E
N
T
A
T
IO
N
S
111
SafePork 2005
EVALUATION OF PHENOTYPIC AND GENOTYPIC
APPROACHES AS PREDICTORS OF SALMONELLA
STRAINS OF CLINICAL AND NON-CLINICAL ORIGIN
Paul M. Dorr*, Daniel A. Tadesse, Wondwossen Gebreyes
*Department of Population Health and Pathobiology, North Carolina State University – College of Veterinary Medicine, 4700
Hillsborough St., Raleigh, NC, 27606. Ph: 01-919-513-8291; E-mail: wagebrey@ncsu.edu
Summary This study investigated the possible phenotypic and genotypic similarities and differ-
ences between Salmonella isolates obtained from swine with clinical salmonellosis to isolates
obtained from swine showing no clinical disease. Phenotypic analysis was done by antimicrobial
resistance profiling and amplified fragment length polymorphism (AFLP) fingerprinting was
employed for genotypic analysis. A total of 281 (140 clinical and 141 non-clinical) were included in
this study. There was no association between the origin of isolates (clinical or non-clinical) and the
antimicrobial resistance profiles with OR of 0.77 and 95%CI (0.46-1.27). However, there was
association between AFLP profile and origin of isolates (distinct genotypic clustering) between
Salmonella strains of clinical and non-clinical origin with an odds ratio of 8.7 and 95% CI (4.8-
15.9). Therefore, we concluded that a high resolution DNA fingerprinting approach such as AFLP
may be helpful in differentiating strains of primary clinical importance.
Introduction The prevalence of Salmonella in today’s swine production systems continues to be a
threat to the health of both swine and human consumers in the United States. With the emer-
gence and persistence of multi-drug resistant (MDR) isolates in the last few decades, the threat
has become even greater. Current estimates of Salmonella prevalence typically range from
approximately 13% to 25% (Hurd et al., 2002; Davies et al., 1997; Rostagno et al., 2004). Many, if
not a majority of these animals act as carriers and show no outward signs of clinical salmonel-
losis. In addition to the swine harboring and shedding Salmonella, there are many other risk fac-
tors present on and around the farm that increase this risk of infection (Funk et al., 2001). Some
studies have shown a link between virulence and antimicrobial resistance (Navarre et al., 2005)
while others failed to demonstrate a link between these two phenotypes under experimental con-
ditions (Allen et al., 2001). On the other hand, the use of molecular epidemiological approaches
has recently emerged as important components that may be useful for distinguishing Salmonella
strains. Their use, however, as important predictors of clinically significant strains have not yet
been elucidated  The purpose of this study was to compare the phenotypic and genotypic profiles
of isolates obtained from primary clinical salmonellosis cases in swine to isolates obtained from
clinically normal swine in North Carolina and evaluate the significance of phenotypic (based on
antimicrobial resistance pattern) and genotypic (based on AFLP fingerprinting) approaches as pre-
dictors of strains that originated from clinical specimens.
Materials and Methods Clinical
Salmonella isolates were obtained from
two different laboratories. All isolates
were from clinical salmonellosis cases in
North Carolina. The total number of clini-
cal isolates included in the present study
was 140. Of these, ninety were donated
from the NCDA diagnostic laboratory.
These represent clinical cases from mul-
tiple swine production systems through-
out North Carolina. Additional 50 clinical
isolates originated from Lab 2 that repre-
sent clinical cases from multiple farms in
one production system. Non-clinical iso-
lates (n=141) were obtained from previ-
ous and ongoing prevalence studies
within the lab and were used as a convenience sam-
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Figure 1. Comparison of antimicrobial resistance pro-
files between Salmonella isolates originated from
clinical (n=140) and non-clinical (n= 141) sources.
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ple (n=141). Antimicrobial susceptibility testing was performed using the following antimicrobials
as published previously: ampicillin (A; 10 µg), amoxicillin-clavulanic acid (Ax; 30 µg), amikacin (An;
30 µg), ceftriaxone (Cro; 30 µg), cephalothin (Cf; 30 µg), chloramphenicol (C; 30 µg), ciprofloxacin
(Cip; 5 µg), gentamicin (G; 10 µg), kanamycin (K; 30 µg), streptomycin (S; 10 µg), sulfasoxazole (G;
250 µg), and tetracycline (T; 30 µg) (Gebreyes et al., 2005).  
Amplified Fragment Length Polymorphism (AFLP) fingerprinting was carried out on all the 141
isolates as described previously (Gebreyes et al., 2005).  Purified DNA was adjusted to a concen-
tration of 10ng/µl nuclease free water (Fisher Scientific, Fair Lawn, New jersey, USA).  We used a
modification of the AFLP protocol first described by Vos et al (1995). Briefly, the DNA was digest-
ed with EcoRI and MseI enzymes mix (LI-COR® Biosciences, Lincoln, NE, USA) at 37oC for 2
hours and incubated for 15 minutes at 70oC. Then adapters were ligated to the restriction frag-
ments using T4 DNA ligase at 20oC for 2 hours. The ligation mixtures were diluted 1:10 using TE
buffer (LI-COR® Biosciences, Lincoln, NE, USA) and fragments were amplified using EcoRI and
MseI primers (Integrated DNA Technologies, Coralville, IA, USA) for 20 cycles at 94oC for 30 sec-
onds, 56oC for 1 minute, and 72oC for 1 minute. Selective amplifications were performed on a 1:10
diluted pre-amplification template using MseI (Integrated DNA Technologies, Coralville, IA, USA)
and IRDye 800 labeled EcoRI (LI-COR® Biosciences, Lincoln, NE, USA) primer with an additional
adenine at EcoRI 3’ end to obtain optimum band for analysis. Fragments were visualized on LI-
COR 4200 DNA sequencer using 6.5 % KBPLUS polyacrylamide denaturing gel (LI-COR®
Biosciences, Lincoln, NE, USA).
Statistical analysis was done using Odds ration (OR computation for association between phe-
notype or genotype and origin of isolates and a 95% confidence interval (CI) was computed to
determine the variability and statistical significance of the association.
Results Out of the twelve antimicrobials tested for overall resistance pattern analysis, Ceftriaxone
(Cro) was the only antibiotic that showed a significant difference in resistance between the clini-
cal and nonclinical isolates.  Phenotypic variability was also analyzed between the clinical and non-
clinical isolates using the penta-resistance pattern common to the Salmonella phage type DT104,
ACSSuT. No difference in this pentaresistance pattern was found between the clinical and non-
clinical isolates (OR 0.77, 95%CI 0.46, 1.27).
For the AFLP analysis, a cutoff of 70% was used to identify major clusters as recommended
previously (Gebreyes et al., 2005).  A total of 17 clonal types were identified.  Using this finger-
printing approach, we detected a clear distinction between clonal types of clinical and non-clinical
origin. A subset of this is demonstrated on Figure 2. As shown in the figure, two clusters pre-
dominantly of clinical origin: 1A (14 of 17 were clinical) and 1b (17 of 21 were clinical) and three
clusters of predominantly isolates of non-clinical origin: cluster 2 (all five were from non-clinical
source), cluster 3 (all eight were from non-clinical source) and cluster4 (12 of 13 were of non-clini-
cal origin) were identified. There was a statistically significant association between AFLP profile
and origin of isolates (clinical or non-clinical) with an odds ratio (OR) of 8.7 and 95% CI (4.77,
15.86).  
Discussion The vast phenotypic similarities interspersed between the clinical and non-clinical iso-
lates may indicate that Salmonella strains antimicrobial resistance may not be associated with the
occurrence of Salmonella strains in clinical illneses. Furthermore, this strengthens the argument
that the difference in virulence between these isolates is multi-factorial and may not be strictly
linked to antimicrobial resistance. Differences in production systems (1, 2, and 3 site production),
environmental stressors, health status (PRRS, PCV positive herds), and nutrition may all play an
important role in the expression of clinical salmonellosis in these swine herds. On the other hand,
there was a lot of genotypic similarity within the clinical and non-clinical isolates. This may indi-
cate that the use of AFLP could be a good predictor of Salmonella strain that are most commonly
associated with clinical illnesses. This is a preliminary study that used convenience samples.
Further work with this data including various host, pathogen and environmental factors is needed.
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Figure 2. Dendrogram showing AFLP fingerprinting analysis of
64 Salmonella isolates from clinical and non-clinical sources.
